Richard Quintiliani
#149,600
Most Influential Person Now
Richard Quintiliani's AcademicInfluence.com Rankings
Richard Quintilianiphilosophy Degrees
Philosophy
#8217
World Rank
#11554
Historical Rank
Logic
#5250
World Rank
#6635
Historical Rank
Richard Quintilianibiology Degrees
Biology
#11090
World Rank
#14465
Historical Rank
Immunology
#709
World Rank
#731
Historical Rank
Download Badge
Philosophy Biology
Richard Quintiliani's Degrees
- Bachelors Biology University of California, Berkeley
- Doctorate Medicine University of California, San Francisco
- PhD Immunology Stanford University
Similar Degrees You Can Earn
Why Is Richard Quintiliani Influential?
(Suggest an Edit or Addition)Richard Quintiliani's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A Controlled Clinical Trial of E5 Murine Monoclonal IgM Antibody to Endotoxin in the Treatment of Gram-Negative Sepsis (1991) (656)
- Experience with a once-daily aminoglycoside program administered to 2,184 adult patients (1995) (581)
- Clinical, epidemiologic and bacteriologic observations of an outbreak of methicillin-resistant Staphylococcus aureus at a large community hospital. (1976) (233)
- Pharmacodynamic Comparisons of Levofloxacin, Ciprofloxacin, and Ampicillin against Streptococcus pneumoniae in an In Vitro Model of Infection (1999) (229)
- The pharmacodynamics of aminoglycosides. (1998) (219)
- Pharmacokinetics and clinical use of cephalosporin antibiotics. (1975) (215)
- Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin (1996) (179)
- Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia. (2001) (158)
- The vanB gene confers various levels of self-transferable resistance to vancomycin in enterococci. (1993) (151)
- Oral bacitracin vs vancomycin therapy for Clostridium difficile-induced diarrhea. A randomized double-blind trial. (1986) (138)
- Clinical Efficacy and Pharmacoeconomics of a Continuous‐Infusion Piperacillin‐Tazobactam Program in a Large Community Teaching Hospital (2002) (130)
- Characterization of Tn1547, a composite transposon flanked by the IS16 and IS256-like elements, that confers vancomycin resistance in Enterococcus faecalis BM4281. (1996) (123)
- Gram-negative bacillary meningitis. (1975) (119)
- Economic impact of streamlining antibiotic administration. (1987) (118)
- Conjugal transfer of the vancomycin resistance determinant vanB between enterococci involves the movement of large genetic elements from chromosome to chromosome. (1994) (118)
- Mechanisms of glycopeptide resistance in enterococci. (1996) (117)
- Regulation of VanA- and VanB-Type Glycopeptide Resistance in Enterococci (2001) (115)
- Trimethoprim-sulfamethoxazole for bacterial meningitis. (1984) (107)
- Antibiotic streamlining from combination therapy to monotherapy utilizing an interdisciplinary approach. (1988) (107)
- Vancomycin Therapeutic Drug Monitoring: Is it Necessary? (1993) (98)
- The penetration characteristics of cefazolin, cephalothin, and cephradine into bone in patients undergoing total hip replacement. (1977) (96)
- Serum bactericidal activity of ceftazidime: continuous infusion versus intermittent injections (1996) (91)
- Penetration of amoxicillin, cefaclor, erythromycin-sulfisoxazole, and trimethoprim-sulfamethoxazole into the middle ear fluid of patients with chronic serous otitis media. (1982) (86)
- Defective regulation of chemotaxis in cirrhosis. (1975) (82)
- Development of meningitis during cephalothin therapy. (1973) (82)
- Pharmacokinetics of vancomycin in anuria. (1981) (80)
- The CroRS Two-Component Regulatory System Is Requiredfor Intrinsic β-Lactam Resistance in Enterococcusfaecalis (2003) (79)
- Pharmacokinetics of trimethoprim and sulfamethoxazole in serum and cerebrospinal fluid of adult patients with normal meninges (1984) (75)
- A common source outbreak of Acinetobacter pulmonary infections traced to Wright respirometers. (1980) (72)
- Cost‐Effectiveness of Ceftazidime by Continuous Infusion versus Intermittent Infusion for Nosocomial Pneumonia (2001) (72)
- Meningovascular syphilis after 'appropriate' treatment of primary syphilis. (1982) (70)
- Pneumonia due to Pseudomonas aeruginosa: part II: antimicrobial resistance, pharmacodynamic concepts, and antibiotic therapy. (2011) (70)
- Reduction of bacterial titers by low-dose aspirin in experimental aortic valve endocarditis (1993) (68)
- Clinical Pharmacokinetics of Ceftriaxone (1989) (68)
- Pharmacodynamics and Pharmacokinetics of Levofloxacin (2000) (67)
- Influence of aspirin on development and treatment of experimental Staphylococcus aureus endocarditis (1995) (66)
- Pharmacoeconomics of a pharmacist-managed program for automatically converting levofloxacin route from i.v. to oral. (2002) (63)
- Treatment of nocardial infection with trimethoprim and sulfamethoxazole. (1974) (62)
- Microbial pharmacodynamics of piperacillin in neutropenic mice of systematic infection due toPseudomonas aeruginosa (1988) (61)
- Therapy of Mycobacterium marinum infections. Use of tetracyclines vs rifampin. (1986) (60)
- Prophylaxis of oral candidiasis with clotrimazole troches. (1984) (60)
- Bioavailability and pharmacokinetics of ofloxacin in healthy volunteers (1991) (57)
- Acute exacerbation of chronic bronchitis: a primary care consensus guideline. (2004) (57)
- A pharmacodynamic model for the activity of antibiotics against microorganisms under nonsaturable conditions. (1986) (57)
- Genetics of glycopeptide resistance in enterococci. (1996) (56)
- Bacteremic Pseudomonas pneumonia. (1974) (55)
- Cellulitis due to Streptococcus pneumoniae: case report and review. (1992) (53)
- Efficacies of liposome-encapsulated clarithromycin and ofloxacin against Mycobacterium avium-M. intracellulare complex in human macrophages (1994) (52)
- Evaluation of the efficacy of ciprofloxacin against Streptococcus pneumoniae by using a mouse protection model (1993) (52)
- Combination antibiotic therapy: comparison of constant infusion and intermittent bolus dosing in an experimental animal model. (1985) (50)
- Antibiotic kinetics and dynamics for the clinician. (1995) (50)
- Clinical experience on the detection of endotoxemia with the limulus test. (1973) (49)
- Relative bioavailability in healthy volunteers of ciprofloxacin administered through a nasogastric tube with and without enteral feeding (1989) (49)
- The association of bacteremic Haemophilus influenzae pneumonia in adults with typable strains. (1971) (47)
- Comparison of concentrations of amoxicillin and ampicillin in serum and middle ear fluid of children with chronic otitis media. (1977) (47)
- Strategic antibiotic decision-making at the formulary level. (1991) (46)
- Severe diarrhea controlled by gamma globulin in a patient with agammaglobulinemia, amyloidosis, and thymoma. (1966) (46)
- Once-daily aminoglycoside dosing: impact on requests and costs for therapeutic drug monitoring. (1996) (46)
- Treatment and prevention of oropharyngeal candidiasis. (1984) (45)
- Clinical Pharmacokinetics of Newer Cephalosporins (1995) (44)
- Optimal times above MICs of ceftibuten and cefaclor in experimental intra-abdominal infections (1994) (42)
- Pharmacodynamic profiling of continuously infused piperacillin/tazobactam against Pseudomonas aeruginosa using Monte Carlo analysis. (2002) (42)
- In vitro antimicrobial susceptibility of glycopeptide-resistant enterococci. (1995) (42)
- Failure of disposable domes to prevent septicemia acquired from contaminated pressure transducers. (1978) (42)
- Teicoplanin pharmacokinetics in healthy volunteers after administration of intravenous loading and maintenance doses (1990) (41)
- Pharmacokinetic and pharmacodynamic profile of high dose extended interval piperacillin-tazobactam. (2001) (40)
- Comparative efficacies of levofloxacin and ciprofloxacin against Streptococcus pneumoniae in a mouse model of experimental septicaemia. (1999) (39)
- Treatment of prosthetic valve endocarditis due to methicillin-resistant Staphylococcus aureus with minocycline. (1990) (39)
- Pharmacokinetic and Pharmacodynamic Evaluation of Two Dosing Regimens for Piperacillin‐Tazobactam (2002) (39)
- Intracellular and extracellular penetration of azithromycin into inflammatory and noninflammatory blister fluid (1994) (38)
- Overwhelming sepsis associated with group A beta hemolytic streptococci. (1971) (38)
- Pharmacokinetics of single- and multiple-dose teicoplanin in healthy volunteers (1989) (38)
- Minocycline versus vancomycin for treatment of experimental endocarditis caused by oxacillin-resistant Staphylococcus aureus (1994) (38)
- Mycoplasma pneumoniae meningoencephalitis and transverse myelitis in association with low cerebrospinal fluid glucose. (1976) (38)
- Aminoglycoside antibiotics moderately impair granulocyte function (1978) (37)
- Comparison of the bactericidal activities of ofloxacin and ciprofloxacin alone and in combination with ceftazidime and piperacillin against clinical strains of Pseudomonas aeruginosa (1995) (36)
- Bioavailability of fluconazole administered via a feeding tube in intensive care unit patients. (1995) (36)
- Endocarditis from Serratia marcescens. (1969) (34)
- In vitro elution of ofloxacin from a bioabsorbable polymer. (1995) (33)
- The atypical pneumonias: a diagnostic and therapeutic approach. (1979) (32)
- Further observations on the antimicrobial effects of local anesthetic agents. (1975) (32)
- Treatment of multidrug-resistant Pseudomonas aeruginosa with ceftolozane/tazobactam in a critically ill patient receiving continuous venovenous haemodiafiltration. (2016) (32)
- Effect of protein binding on drug penetration into blister fluid (1988) (32)
- Rifampin-Fluconazole Interaction in Critically ILL Patients (1995) (32)
- Comparative Pharmacokinetics, Pharmacodynamics, and Tolerability of Ertapenem 1 Gram/Day Administered as a Rapid 5‐Minute Infusion versus the Standard 30‐Minute Infusion in Healthy Adult Volunteers (2013) (31)
- Transitional Antibiotic Therapy (1995) (31)
- Pharmacokinetics of High-Dose Meropenem in Adult Cystic Fibrosis Patients (2001) (31)
- Absorption of vancomycin. (1984) (29)
- In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa. (2000) (29)
- Pharmacokinetics of cefotaxime in healthy volunteers and patients. (1995) (28)
- New generations of quinolones: with particular attention to levofloxacin. (1997) (28)
- Absorption of ciprofloxacin in patients with diabetic gastroparesis (1995) (27)
- Flavobacterium meningosepticum meningitis in a newborn infant (1974) (27)
- Antibiotic formulary selection. (1995) (26)
- Partial characterization of a cell-directed inhibitor of leukotaxis in human serum. (1977) (26)
- Review of cefonicid, a long-acting cephalosporin. (1984) (26)
- Pharmacokinetic and Pharmacodynamic Considerations in Antibiotic Selection, with Particular Attention to Oral Cephalosporins (1994) (26)
- The pharmacokinetics of metronidazole and its metabolites in critically ill patients. (1988) (25)
- Streptococcus pneumoniae Response to Repeated Moxifloxacin or Levofloxacin Exposure in a Rabbit Tissue Cage Model (2001) (25)
- Bacteraemia after manipulation of the urinary tract. The importance of pre-existing urinary tract disease and compromised host defences. (1978) (25)
- Beneficial Effect of Adjunctive Azithromycin in Treatment of Mucoid Pseudomonas aeruginosa Pneumonia in the Murine Model (1999) (25)
- Effect of saturable serum protein binding on the pharmacokinetics of unbound cefonicid in humans (1986) (25)
- Pharmacokinetics and Pharmacodynamics of Continuous and Intermittent Ceftazidime during the Treatment of Nosocomial Pneumonia (1999) (25)
- Absorption of ciprofloxacin administered through a nasogastric or a nasoduodenal tube in volunteers and patients receiving enteral nutrition. (1990) (25)
- Antibiotic Prophylaxis in Eyes with Filtration Blebs: Survey of Glaucoma Specialists, Microbiological Study, and Recommendations (1995) (25)
- Pharmacokinetics and penetration characteristics of cefazolin into human spinal fluid. (1976) (24)
- Oral bioavailability and pharmacokinetics of ciprofloxacin in patients with AIDS (1997) (24)
- Drugs Five Years Later: Cefazolin (1978) (23)
- Cost comparison of single daily i.v. doses of ceftriaxone versus continuous infusion of cefotaxime. (1997) (23)
- PHARMACOKINETICS OF CONTINUOUS AND INTERMITTENT CEFTAZIDIME IN INTENSIVE CARE UNIT PATIENTS WITH NOSOCOMIAL PNEUMONIA (1999) (23)
- Assessment of Clostridium difficile Burden in Patients Over Time With First Episode Infection Following Fidaxomicin or Vancomycin (2015) (23)
- Influence of adjunctive ticlopidine on the treatment of experimental Staphylococcus aureus endocarditis. (1998) (23)
- Bactericidal activity of low-dose clindamycin administered at 8- and 12-hour intervals against Staphylococcus aureus, Streptococcus pneumoniae, and Bacteroides fragilis (1997) (22)
- Comparative penetration of cefonicid and cefazolin into the atrial appendage and pericardial fluid of patients undergoing open-heart surgery (1984) (22)
- In vitro synergistic activities of tobramycin and selected beta-lactams against 75 gram-negative clinical isolates (1997) (22)
- Limitations of single point pharmacodynamic analysis. (2000) (22)
- In vivo inactivation of tobramycin by ticarcillin. A case report. (1982) (22)
- Comparison of vancomycin pharmacodynamics (1 g every 12 or 24 h) against methicillin-resistant staphylococci. (2000) (22)
- Restriction policies for therapy with combination antibiotics. (1986) (22)
- Pharmacokinetics of Oral Cephalosporins: Cephradine and Cephalexin (1978) (22)
- Physiological perfusion model for cephalosporin antibiotics I: Model selection based on blood drug concentrations. (1978) (21)
- Inhalational anthrax and bioterrorism (2003) (21)
- Enterococcal infections in a large community hospital, with emphasis on bacteremia. (1980) (21)
- PHARMACOKINETIC AND ECONOMIC EVALUATION OF PIPERACILLIN/TAZOBACTAM ADMINISTERED AS EITHER CONTINUOUS OR INTERMITTENT INFUSION WITH ONCE-DAILY GENTAMIC IN (1999) (21)
- In vitro activity of cefonicid, ceforanide, and cefazolin against Staphylococcus aureus and Staphylococcus epidermidis and the effect of human serum. (1983) (21)
- Penetration characteristics of trimethoprim-sulfamethoxazole in middle ear fluid of patients with chronic serous otitis media. (1980) (20)
- Comparative pharmacokinetics of cefotaxime and ceftizoxime and the role of desacetylcefotaxime in the antibacterial activity of cefotaxime. (1984) (20)
- Prediction of gentamicin serum levels using a one-compartment open linear pharmacokinetic model. (1978) (20)
- Pharmacokinetics and pharmacodynamics of total and unbound cefoxitin and cefotetan in healthy volunteers. (1989) (20)
- Streamlining antimicrobial therapy for lower respiratory tract infections. (1997) (20)
- A Prospective Analysis of Hospital-Acquired Fever in Obstetric and Gynecologic Patients (1982) (20)
- Treatment of Serratia marcescens Meningitis with Prolonged Infusion of Meropenem (2007) (20)
- Characterization of bactericidal activity of clindamycin against Bacteroides fragilis via kill curve methods (1996) (19)
- Effect of sucralfate on pharmacokinetics of fleroxacin in healthy volunteers (1992) (19)
- Evaluation of an oral prolonged-release antibiotic formulation. (1978) (19)
- Pharmacodynamics and tolerability of high-dose, prolonged infusion carbapenems in adults with cystic fibrosis – A review of 3 cases (2010) (19)
- Disappearing "gallstones": biliary pseudolithiasis complicating ceftriaxone therapy. (1992) (19)
- Comparative Pharmacokinetic and Pharmacodynamic Profile of Piperacillin/Tazobactam 3.375G Q4H and 4.5G Q6H (2002) (18)
- Fatal case of inhalational anthrax mimicking intra-abdominal sepsis. (2002) (18)
- Influence of gentamicin dosing interval on the efficacy of penicillin-containing regimens in experimental Enterococcus faecalis endocarditis. (1997) (18)
- PHARMACOECONOMIC EVALUATION OF ALTERNATIVE ANTIBIOTIC REGIMENS IN HOSPITALIZED PATIENTS WITH COMMUNITY‐ACQUIRED PNEUMONIA (1998) (18)
- Fatal case of inhalational anthrax mimicking intra-abdominal sepsis. (2002) (18)
- High teicoplanin uptake by human neutrophils. (1988) (18)
- Penetration of ceforanide and cefamandole into the right atrial appendage, pericardial fluid, sternum, and intercostal muscle of patients undergoing open heart surgery (1982) (18)
- Comparison of the bactericidal activities of piperacillin-tazobactam, ticarcillin-clavulanate, and ampicillin-sulbactam against clinical isolates of Bacteroides fragilis, Enterococcus faecalis, Escherichia coli, and Pseudomonas aeruginosa (1997) (17)
- SESSION II RESPIRATORY TRACT INFECTIONS: TRANSITIONAL ANTIBIOTIC THERAPY (1994) (17)
- Ciprofloxacin levels when receiving sucralfate. (1989) (17)
- Penetration characteristics of cefamandole into the right atrial appendage and pericardial fluid in patients undergoing open-heart surgery. (1980) (17)
- Intelligent dosing of antimicrobials. (1994) (16)
- Cost Issues and Considerations When Choosing Antimicrobial Agents (1994) (16)
- Pharmacodynamic study of β-lactams alone and in combination with β-lactamase inhibitors against Pseudomonas aeruginosa possessing an inducible β-lactamase (2004) (16)
- Antibiotic use in the critical care unit. (1998) (16)
- COST-EFFECTIVENESS ANALYSIS OF CEFEPIME COMPARED WITH CEFTAZIDIME IN INTENSIVE CARE UNIT PATIENTS WITH HOSPITAL-ACQUIRED PNEUMONIA (1999) (16)
- Comparison of four methods of predicting serum gentamicin concentrations in adult patients with impaired renal function. (1982) (16)
- Multidisciplinary cost-containment program promoting oral metronidazole for treatment of antibiotic-associated colitis. (1988) (16)
- Synergism of Cefazolin-Gentamicin Against Enterococci (1976) (16)
- Efficacy of vancomycin and teicoplanin alone and in combination with streptomycin in experimental, low-level vancomycin-resistant, VanB-type Enterococcus faecalis endocarditis (1996) (15)
- Pharmacodynamics of ceftriaxone and cefixime against community-acquired respiratory tract pathogens. (2001) (15)
- Stability of meropenem in a portable infusion device in a cold pouch. (2000) (15)
- Penetration of cephalosporins into bone (1984) (15)
- Minocycline: old and new therapeutic uses. (1994) (15)
- Pharmacokinetics of Doripenem in Infected Patients Treated Within and Outside the Intensive Care Unit (2013) (14)
- Effect of protein binding on the penetration of nonmetabolized cephalosporins into atrial appendage and pericardial fluids in open-heart surgical patients (1980) (14)
- CLINICAL ROLE OF FLUOROQUINOLONES IN PATIENTS WITH RESPIRATORY TRACT INFECTIONS (1999) (14)
- Cefixime in the treatment of patients with lower respiratory tract infections: results of US clinical trials. (1996) (14)
- Polymyxin B in the treatment of Klebsiella pneumoniae meningoventriculitis. Intraventricular and intrathecal administration. (1971) (14)
- Tissue penetration and half-life of cefonicid. (1984) (14)
- Pharmacokinetics of nafcillin in obesity. (1988) (14)
- Implementation of a once-daily aminoglycoside program in a large community-teaching hospital. (1995) (14)
- Myocardial dysfunction and hemolytic anemia in a patient with Mycoplasma pneumoniae infection. (1977) (14)
- Pharmacokinetics/Pharmacodynamics for critical care clinicians. (2008) (13)
- Activity of Minocycline Against Acinetobacter calcoaceticus Var. anitratus (Syn. Herellea vaginicola) and Serratia Marcescens (1975) (13)
- Current concepts in the treatment of staphylococcal meningitis. (1988) (13)
- A review of the penetration of cefadroxil into human tissue. (1982) (13)
- Pharmacokinetics/Pharmacodynamics for critical care clinicians. (2008) (13)
- Using pharmacodynamic and pharmacokinetic concepts to optimize treatment of infectious diseases (2004) (12)
- First and second generation cephalosporins. (1982) (12)
- Moxifloxacin does increase the corrected QT interval. (2001) (12)
- Cerebrospinal fluid penetration of trimethoprim-sulphamethoxazole in two patients with gram-negative bacillary meningitis. (1984) (12)
- Principles of antibiotic usage. (1984) (12)
- Penetration of cephapirin and cephalothin into the right atrial appendage and pericardial fluid of patients undergoing open-heart surgery. (1979) (12)
- Severe sepsis from Enterobacter. (1973) (12)
- Comparative pharmacokinetics of cefotetan and cefoxitin in patients undergoing hysterectomies and colorectal operations. (1988) (12)
- Pharmacokinetics of minocycline and vancomycin in rabbits. (1993) (12)
- Bleeding disorders associated with newer cephalosporins. (1983) (12)
- Determination of the in vivo post-antibiotic effects of ciprofloxacin and rifampicin. (1995) (11)
- Hormonal adaptation to real and simulated microgravity. (1998) (11)
- Multidisciplinary program for promoting single prophylactic doses of cefazolin in obstetrical and gynecological surgical procedures. (1988) (11)
- Circulating Tumor Necrosis Factor-Alpha Production during the Progression of Rat Endotoxic Sepsis (2001) (11)
- Multidisciplinary cost-containment program promoting less frequent administration of injectable mezlocillin. (1988) (11)
- Flavobacterium meningosepticum meningitis in a newborn infant. Treatment with intraventricular erythromycin. (1974) (11)
- Influence of adjunctive interferon-gamma on treatment of gentamicin- and vancomycin-resistant Enterococcus faecalis infection in mice. (1999) (11)
- Comparison of the Bactericidal Activity of Trovafloxacin and Ciprofloxacin, Alone and in Combination with Cefepime, against Pseudomonas aeruginosa (2000) (11)
- Penetration of fleroxacin and ciprofloxacin into skin blister fluid: a comparative study (1992) (10)
- The Relative Bioavailability of Temafloxacin Administered through a Nasogastric Tube With and Without Enterai Feeding (1992) (10)
- Concentrations of ceftriaxone in gallbladder wall, bile, and serum in patients undergoing cholecystectomy. (1987) (9)
- An improved method to determine interstitial fluid pharmacokinetics. (1985) (9)
- Effect of including recommendations for antimicrobial therapy in microbiology laboratory reports. (1991) (9)
- Extended-spectrum beta-lactamases (ESBL). (2002) (9)
- CEFIXIME: A PHARMACOECONOMIC PERSPECTIVE (1996) (8)
- Changes in pharmacokinetics of cefazolin due to stress. (1975) (8)
- Loss of bactericidal activities of quinolones during the post-antibiotic effect induced by rifampicin. (1994) (8)
- Continuous Infusion β-Lactams: A Pharmacodynamic Approach (1996) (8)
- Comparative pharmacokinetics of ceftizoxime and other third-generation cephalosporins in humans. (1982) (8)
- Antibacterials for the Prophylaxis and Treatment of Bacterial Endocarditis in Children (2001) (8)
- Continuous infusion of beta-lactam antibiotics. (1999) (8)
- Oral Bioavailability and Pharmacokinetics of Trovafloxacin in Patients with AIDS (1999) (8)
- Severe meningoencephalitis: complicating Mycoplasma pneumoniae infection in a child. (1981) (8)
- A comparison of the penetration characteristics of cephapirin and cephalothin into right atrial appendage, muscle, fat, and pericardial fluid of pediatric patients undergoing open-heart operation. (1981) (8)
- Effect of stress on the pharmacokinetics of amikacin and ticarcillin. (1987) (8)
- Pharmacokinetics and Pharmacoeconomic Evaluation of Ticarcillin-Clavulanate Administered as Either Continuous or Intermittent Infusion with Once-Daily Gentamicin (1999) (8)
- Influence of ticlopidine on the development of experimental Staphylococcus aureus endocarditis. (1996) (8)
- Voriconazole: A novel azote antifungal (2002) (8)
- Protective effect of trovafloxacin, ciprofloxacin and ampicillin against Streptococcus pneumoniae in a murine sepsis model. (1999) (8)
- Comparison of bactericidal activity after multidose administration of clarithromycin, azithromycin, and ceruroxime axetil against Streptococcus pneumoniae. (1998) (8)
- Activities of liposome-encapsulated azithromycin and rifabutin compared with that of clarithromycin against Mycobacterium avium-intracellulare complex in human macrophages. (1994) (8)
- PROPHYLACTIC ANTIBIOTICS IN CHOLECYSTECTOMY (1978) (7)
- Procedure for evaluating nonformulary drug orders. (1993) (7)
- Serum bactericidal activity of ceftriaxone plus metronidazole against common intra-abdominal pathogens. (1994) (7)
- Potential role of trimethoprim-sulfamethoxazole in the treatment of serious hospital-acquired bacterial infections. (1987) (7)
- Non-pneumococcal Gram-positive coccal meningitis related to neurosurgery. (1977) (7)
- Choosing between the new cephalosporin antibiotics: a pharmacodynamic approach. (1994) (7)
- Synergistic Activity of Trovafloxacin and Ceftriaxone or Vancomycin against Streptococcus pneumoniae with Various Penicillin Susceptibilities (1998) (7)
- Pseudomonas peritonitis in neutropenic rats treated with amikacin, ceftazidime and ticarcillin, alone and in combination. (1987) (7)
- Comparison of azithromycin leukocyte disposition in healthy volunteers and volunteers with AIDS. (2000) (7)
- Fatal case of influenza pneumonia with suprainfection by multiple bacteria and Herpes simplex virus. (1976) (7)
- Clinical efficacy of cefepime in pneumonia caused by Pseudomonas aeruginosa (2000) (6)
- Pharmacokinetics of oral cephalosporins. (1978) (6)
- Clinical management of respiratory tract infections in the community: experience with telithromycin. (2001) (6)
- Serum bactericidal activity of ceftizoxime and ceftriaxone against pathogens associated with community-acquired and nosocomial pneumonias. (1996) (6)
- Guidelines for treatment of community-acquired pneumonia. (2001) (6)
- Antimicrobial switch therapy. (1998) (6)
- Minimal Interaction between Gatifloxacin and Oxycodone (2002) (6)
- Stability of cefotaxime sodium and metronidazole in 0.9% sodium chloride injection or in ready-to-use metronidazole bags. (1995) (6)
- Pharmacodynamic study of beta-lactams alone and in combination with beta-lactamase inhibitors against Pseudomonas aeruginosa possessing an inducible beta-lactamase. (2004) (6)
- Binding rate of antibacterials to serum proteins. (1977) (6)
- Sultamicillin® use in otitis media: penetration of sulbactam, a beta-lactamase inhibitor, and ampicillin into middle-ear fluid (1985) (5)
- Cefotetan-associated coagulopathies. (1989) (5)
- In vitro reduction of endotoxin concentrations with the 5S fragment of immunoglobulin G (1997) (5)
- Statistical analysis of factors predisposing to candiduria. (1979) (5)
- Continuous infusion of beta-lactam antibiotics: a rational dosing approach. (1995) (5)
- A Prospective Analysis of Hospital‐acquired Fever in Obstetric and Gynecologic Patients (1982) (5)
- Oral ciprofloxacin, ofloxacin, and lomefloxacin as alternatives to intravenous antimicrobial therapy. (1993) (5)
- Hypersensitivity and adverse reactions associated with the use of newer intranasal corticosteroids for allergic rhinitis (1996) (5)
- Absorption of ciprofloxacin in febrile and afebrile patients. (1995) (4)
- Biliary excretion of cefotaxime (1984) (4)
- Influence of adjunct azithromycin on the mortality of experimental Pseudomonas aeruginosa sepsis. (1997) (4)
- Stability of aztreonam and ampicillin sodium-sulbactam sodium in 0.9% sodium chloride injection. (1994) (4)
- Choosing between the New Cephalosporin Antibiotics (2012) (3)
- Ceftazidime to cefepime formulary switch: pharmacodynamic and pharmacoeconomic rationale. (1997) (3)
- The intrathecal and intraventricular administration of antibiotics in central nervous system infections. (1970) (3)
- Strategy for developing a safe and cost-effective H2-receptor antagonist program. (1991) (3)
- The bacteriological examination of sputum. (1974) (3)
- Clindamycin (Cleocin) in bacterial pneumonia. (1970) (3)
- Determining the formulary status of quinolone antibiotics: one institution's approach. (1992) (3)
- Cephalosporin-metronidazole combinations in the management of intra-abdominal infections. (1995) (3)
- pH- and medium-dependent degradation of piperacillin during susceptibility tests on antipseudomonal activity. (1988) (3)
- Lomefloxacin concentrations in bone after a single oral dose. (1992) (3)
- Achieving rational therapeutics through consensus-based protocols and follow-up. (1990) (3)
- Efficacy of a Twice-Daily Regimen of Cefadroxil in the Treatment of Respiratory Tract Infections (2012) (3)
- Use of pharmacodynamic concepts in developing a cost-effective dosing method for piperacillin. (1993) (3)
- Herpes simplex encephalitis: the case against brain biopsy. (1983) (3)
- Impact of dosage regimens on the efficacy of piperacillin against Pseudomonas aeruginosa in neutropenic mice. (1988) (3)
- Serum and Tissue Concentrations of Cefoxitin and Cefamandole in Women Undergoing Hysterectomy (1983) (3)
- Comparison of the Pharmacodynamic Activity of Cefotaxime plus Metronidazole With Cefoxitin and Ampicillin plus Sulbactam (1995) (3)
- Serum and Tissue Concentrations of Cefoxitin and Cefotaxime in Women Undergoing Hysterectomy (2012) (3)
- The conversion of cefoxitin usage to cefotetan: an interdisciplinary approach. (1988) (3)
- Drug therapy for methicillin-resistant Staphylococcus aureus. (2001) (3)
- Comparative serum bactericidal activities of ceftizoxime and cefotaxime against intermediately penicillin-resistant Streptococcus pneumoniae (1996) (3)
- Gentamicin sulfate in infections associated with surgery or trauma. (1976) (2)
- Pharmacoeconomics of Pneumocystis carinii Pneumonia in HIV-Infected and HIV-Noninfected Patients (1996) (2)
- Quinupristin/dalfopristin: a treatment option for vancomycin-resistant Enterococci. (2000) (2)
- Comparison of concentrations of cefonicid and cefoxitin in serum and uterine tissue of patients undergoing hysterectomy (1985) (2)
- Comparison of the efficacy, safety, and therapeutic usage of HA-1A and E5 in the treatment of gram-negative sepsis. (1992) (2)
- Tetracyclines in therapy of Mycobacterium marinum infections. (1987) (2)
- Comparative efficacy and safety of inhaled fluticasone propionate and beclomethasone dipropionate in the treatment of asthma : A review (1997) (2)
- Antibiotic Use and Formulary Considerations (1991) (2)
- Prophylactic antibiotics in prosthetic implant surgery. (1979) (1)
- Transitional (intravenous to oral) antibiotic therapy. (2000) (1)
- Transitional (intravenous to oral) antibiotic therapy. (2000) (1)
- Petechiae in postcardiotomy syndromes. (1970) (1)
- Comparative pharmacokinetics of ceftizoxime and cefotaxime in healthy volunteers (1986) (1)
- Current concepts in therapy: general concepts in the use of antibiotics in adults. (1973) (1)
- Safety and Efficacy of Combining Obstetric and Noninfectious Gynecologic Hospital Patients (1977) (1)
- The Effect of Fleroxacin and Ciprofloxacin on the Pharmacokinetics of Multiple Dose Caffeine (2012) (1)
- Penetration of Fleroxacin and Ciprofloxacin into Skin Blister Fluid: a Comparative Study (1993) (1)
- Pharmacokinetics and cerebrospinal fluid penetration of ceftizoxime in patients undergoing myelography (1984) (1)
- The use of beta-lactam antibiotics in infections--an overview. (1984) (1)
- PHARMACOKINETICS AND CLINICAL USE OF CEPHALOSPORIN ANTIBIOTICS (1976) (1)
- Pneumococcal soft tissue infections in patients with systemic lupus erythematosus. (1995) (1)
- Clinical and microbiological evaluations of fosmidomycin in the treatment of infectious caused by Pseudomonas aeruginosa (1985) (1)
- Ticarcillin (1980) (1)
- When once is enough. Administering aminoglycosides effectively. (1999) (1)
- Penetration of the R and S epimers of moxalactam into synovial fluid (1987) (1)
- Infectious Diseases Society of America position statement on infectious diseases physicians and hospital pharmacists: comment and editorial. (1998) (1)
- The Pharmacokinetic and Pharmacodynamic Attributes of Oral Cephalosporins for Use in Switch Therapy (1996) (1)
- Treatment of uncomplicated infections caused by Chlamydia trachomatis and Neisseria gonorrhoeae. (1994) (1)
- Clinical Infectious Disease: Clostridia (2008) (1)
- Modern approaches to the chemoprophylaxis of infection (1980) (1)
- Pharmacoeconomic Analysis of Intravenous Push vs Slow Infusion of β-Lactam Antibiotics (1999) (1)
- Cost-effectiveness in the use of antibiotics. (2000) (1)
- Stability of cephalosporins in commercial sera. (1981) (1)
- A study of mucormycosis with special reference to its pathogenesis (1960) (0)
- Serological evidence of Helicobactor pylori is associated with familial history of stomach cancer in patients relocated from puerto rico to the Northeastern US (1998) (0)
- The association of mesenteric lymphadenitis with a scotochromogenic mycobacterium. (1971) (0)
- The use of zidovudine to prevent perinatal transmission of HIV. (1995) (0)
- Introduction (2001) (0)
- Effect of mucin on the pharmacokinetics of antibiotics in the rat (1987) (0)
- Pharmacokinetics of oral cephalosporins: cephradine cephalexin. (1978) (0)
- Conversion from Intravenous to Oral Ciprofloxacin: Observing the “Like-to-Like” Phenomenon (1994) (0)
- Herpes simplex encephalitis: the case against brain biopsy. (1991) (0)
- Daptomycin: A Viewpoint by Richard Quintiliani (2004) (0)
- Intracellular and Extracellular Penetration of Azithromycin into Inflammatory and Noninflammatory Blister Fluid (1995) (0)
- Bioavailability andPharmacokinetics ofOfloxacin in Healthy Volunteers (1991) (0)
- Non-prescription medications from health food stores--a potential source of serious illness. (1971) (0)
- Drs. Klimek and Quintiliani Reply (1977) (0)
- Clinical manifestations and antibiotic treatment of Lyme disease. (1992) (0)
- Introduction. Designing a transition therapy program. (2001) (0)
- Modern approaches to the chemoprophylaxis of infection in abdominal surgery. (1980) (0)
- On patient compliance with medication doses. (1997) (0)
- A Pharmacokinetic Method of Assessing Antibiotics Exhibiting an Appreciable Postantibiotic Effect (2012) (0)
- Antibiotic combination therapy in post-traumatic infections. (1979) (0)
- How to create a therapeutics committee that is scientifically and economically sound (2003) (0)
- Current Issues Involved in the Treatment of Community-Acquired Pneumonia (2003) (0)
- Optimizing clinical outcomes by the use of pharmokinetic and pharmacodynamic principles. (2000) (0)
- Commentary 2 (2012) (0)
- Trovafloxacin: fourth generation fluoroquinolone. (1998) (0)
- Inadequate mixing in microdilution wells during preparation of antimicrobial dilutions for susceptibility testing (1988) (0)
- Consensus among Participants for the Treatment of Community-Acquired Pneumonia: Results of the Postsymposium Interactive Question and Answer Session (2000) (0)
- Relative bioavailability of crushed tebipenem administered through a nasogastric tube with and without enteral feeding. (2022) (0)
- Quantitation of Clostridium difficile in Patients With First Episode Infection Following Fidaxomicin or Vancomycin (2015) (0)
- Subject Index Vol. 46, 2000 (2000) (0)
- Evaluation of Nephrotoxicity Associated with Once-Daily Administration of Aminoglycoside (1997) (0)
- Newly recognized infectious diseases. (1979) (0)
- Contents, Vol. 46, 2000 (2000) (0)
- [The prescription of injectable cephalosporins for community-acquired infections in Italy: use or abuse?]. (1997) (0)
- First and Second Generation Cephalosporins (1982) (0)
- Commentary 4 (2012) (0)
- The Bacteriological Exam ination o f Sputum (2015) (0)
- On Patient Compliance With Medication Doses/Dr. Altemeier responds (1997) (0)
- Formulary review of the carbapenems: comparison of imipenem/cilastatin and meropenem. (1998) (0)
- "Should she or shouldn't she" receive the rubella immunization before age 12. (1978) (0)
- Current Opinion in the Treatment of Community-Acquired Pneumonia: Results of the Presymposium Interactive Question and Answer Session (2000) (0)
- Drugs Five Years Later (2020) (0)
- TherapyConcepts, and Antibiotic : Part II: Antimicrobial Resistance, Pseudomonas aeruginosa Pneumonia Due to (2011) (0)
- ofloxacin in healthy volunteers. Bioavailability and pharmacokinetics of (2013) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Richard Quintiliani?
Richard Quintiliani is affiliated with the following schools:
